Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. But is its future as sunny? Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug ...

ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of a drug used to treat epilepsy. The agency approved Mylan’s divalproex sodium delayed-release tablets in the 125 mg, ...

Depakote ER is an extended-release drug, also available as Divalproex Sodium ER generic, that can be prescribed to treat certain types of seizure disorders, including complex partial seizures as well ...

Divalproex sodium 250mg, 500mg; ext-rel tabs. Divalproex sodium dissociates to the valproate ion in the gastrointestinal tract. The mechanisms by which valproate exerts its therapeutic effects have ...

Dr. Reddy's Laboratories Ltd. (RDY) recently announced the launch of its therapeutic equivalent generic version of Depakote ER. Depakote ER is approved for the treatment of acute manic episodes ...

Abbott Laboratories said it will pay $1.6 billion to settle federal and state claims resulting from an investigation into its epilepsy medication Depakote, the second-largest drug-marketing settlement ...

Scientists recommended last week that the Food and Drug Administration approve an epilepsy drug to treat manic-depression, making it the first new drug for the devastating mental illness in 25 years.

Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug is mainly used in the treatment of bipolar disorder, migraines, and seizures. The brand and its generic ...